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Abstract 
A 30-year-old woman was admitted to our hospital with severe shortness of breath. A 
transthoracic echocardiogram showed moderate pericardial effusion with a lesion in the 
right atrium, confirmed by chest CT scan and cardiac RMN. Pleural and middle lobe 
involvement occurred within one month. Middle lobe biopsy was performed and 
pathological examination confirmed the diagnosis of metastatic angiosarcoma. After two 
months, because of recurrent pleural effusions, chemical pleurodesis was performed. 
Chemotherapy was started but the patient died four months after the diagnosis. This 
case highlights the misdiagnosis at initial clinical presentation, available diagnostic 
approaches and therapeutic options for cardiac angiosarcoma. 
 
Introduction 
Primary heart tumours are extremely rare in clinical practice, occurring at a frequency 
of 0.11–0.30% in surgical series and only 25% of them are malignant, mainly represented 
by sarcoma (75%) [1–4]. The most common tumours found in the heart are due to 
metastasis, spreading from other organs such as the lungs, breast, pancreas and skin. 
Cardiac angiosarcoma is a highly aggressive tumour originating from mesenchymal tissue 
and endothelial subepicardium. It involves the left side of the heart more frequently than 
the right side [5]. It can occur at any age but the highest incidence is between the 3rd and 
5th decade of life [6]. 
Clinical presentation is usually unspecific and can vary depending on the dimension 
and the site of the tumour. Increasing dyspnoea, peripheral oedema, cava vein syndrome, 
lung oedema, arrythmia, weakness, syncopation and dizziness are the most common 
symptoms. Potentially mortal complications are represented by pericardial effusion and 
thromboembolic events [7, 8].  
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The diagnosis of primary heart tumours is difficult and needs several tests such as 
electrocardiogram, chest X-ray, transthoracic echocardiogram, computerized spiral 
tomography (CT) and magnetic resonance (cardiac RMN). Cardiac angiosarcomas have 
usually poor prognosis due to late diagnosis and a generally rapid and fatal development. 
Median survival is 11 months [9–14], ranging from 2 months to 2 years. 
The therapeutic approach has often a palliative purpose and includes surgery, 
chemotherapy and radiation therapy [15, 16]. 
Case Report 
A 30-year-old woman was admitted to our department with acute dyspnoea and chest pain. The 
patient denied any cardiovascular or respiratory disease and reported being healthy before the 
symptoms occurred. Blood pressure was normal but the pulse was accelerated (120 bpm). Heart 
auscultation revealed reduced heart sounds; chest examination showed hypophonesis with reduced 
breath sound on the left side. An electrocardiogram showed sinusal tachycardia without acute ischemic 
alterations. Blood test showed haemoglobin 9.5 g/dl, leukocyte count 5,360/μm, platelet count 266 × 
10
3/μm; clotting profile, liver and renal biochemistry were normal. Arterial blood gas analysis revealed 
pH 7.4, PaO2 59 mm Hg and PaCO2 34 mm Hg. Chest X-ray showed a mild cardiomegaly; transthoracic 
echocardiography revealed pericardial effusion and the presence of a hypoechogenic lesion on the left 
atrial wall, with normal left ventricular function. Thereafter a CT scan confirmed the finding of massive 
pericardial effusion and thickening of the left pericardium, no other alterations were reported (fig. 1). 
Pericardiocentesis was performed and 450 ml haemorrhagic fluid were aspirated, followed by 
improvement of the symptoms. The patient was monitored and underwent supportive care therapy. The 
symptoms improved and the patient was discharged after 11 days. 
Thirty days after the first presentation, a second CT scan of the chest was done to monitor the 
evolution of the cardiac findings. The left atrial lesion had increased in size. Multiple lung nodules and 
bilateral pleural effusions were found (fig. 2). Magnetic resonance imaging showed a large mass in the 
atrial left wall, pericardial effusion, thickening of the atrioventricular septum without endoatrial 
thrombus. 
The patient was admitted to the cardiothoracic department and she underwent diagnostic 
thoracoscopy and middle lobe biopsy. The histological examination confirmed the diagnosis of 
pericardial angiosarcoma with pleural and lung metastasis. 
The patient underwent three chemotherapy cycles with myocet, doxorubicin and ifosfamide. 
Because of recurrent pleural effusions, chemical talc pleurodesis was performed but remained ineffective 
in controlling the pleural effusion. A second-line chemotherapy with gemcitabine and docetaxel was 
started. After a few weeks her respiratory symptoms worsened markedly and pleural tube drainage was 
required on both sides (fig. 3). Four months after the diagnosis of primary cardiac angiosarcoma, the 
patient died of severe heart failure. 
Discussion 
The young age of the patient (30 years) and the rapid and fatal development of the 
disease are two of the peculiar aspects common to primary cardiac malignancies. The 
heart is rarely of interest in primary malignant tumours [1–3] and is more often involved 
through metastases originating from the lung or other organs [6, 7, 11]. Symptoms like 
clubbing, haemoptysis and chest pain can be reported but are unspecific and can mimic 
other heart diseases. 
Cardiac angiosarcoma may have different clinical presentations, depending on the size 
and the site. Huang et al. [16] reported the case of a patient with a massive angiosarcoma 
in the right atrium, complaining of chest pain and haemoptysis as first symptoms. The 
authors stressed the crucial role of transoesophageal echography in the assessment of 
cardiac masses.  
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O’Callaghan et al. [13] described a cardiac angiosarcoma mimicking a venous 
thromboembolic disease and underlined the problem that this tumour is often diagnosed 
when it is already advanced. Other possible clinical presentations include heart failure, 
arrhythmia, syncope or fever with pericardial haemorrhagic effusion mimicking 
pericarditis [4, 5, 18]. In our case, the patient was admitted to the hospital complaining of 
acute dyspnoea. Physical examination revealed tachycardia, and a CT scan showed 
thickness of the left pericardium with pleural and pericardial effusion. The diagnosis was 
confirmed by the histological examination of lung biopsy obtained with thorachoscopy, 
performed when the patient had already developed multiple lung metastases. 
Cardiac angiosarcomas with atrial localization often cause superior vena cava 
syndrome and peripheral oedema, while those with ventricular localization can develop 
heart failure symptoms or arrhythmias [9, 12]. Abnormal electrocardiographic findings 
can occur, ranging from asymptomatic conduction disturbances and mild decreases of the 
cardiac electrical potential to fatal arrhythmias [16]. Pulmonary recurrent embolism is a 
quite common complication caused by heart tumours [14]. Angiosarcomas are aggressive 
tumours that can arise from the subepicardial layer and, in most cases, are diagnosed late 
after having already developed metastases. 
Useful examinations for the diagnosis are: (a) echocardiography in order to evaluate 
ventricular cynetic, atrial wall thickening and pericardial effusion [8]; (b) CT and 
magnetic resonance in order to evaluate a lesion’s extension and the involvement of other 
organs [14]. Yang et al. [8] suggested to use the two- and three-dimensional transthoracic 
echocardiography as the gold standard test in the assessment of a cardiac mass. Especially 
the three-dimensional system is an accurate non-invasive technique for defining the
 heart 
mass size, its attachment point and its relationship with other structures. Other authors 
underline the important role of magnetic resonance in detecting heart masses [14]. 
Standard surgery, adjuvant chemotherapy, and radiotherapy have been consistently 
unsuccessful. The surgical treatment [17], if feasible, is still considered the best option 
consisting of an extensive resection of the malignant mass [3]. In these cases, postsurgical 
radiotherapy can improve the median survival [4, 17]. Though several chemotherapeutic 
regimens have been tried, chemotherapy treatment in advanced stages is ineffective and 
not always tolerated by the patients. Adriamycin, cisplatin, ifosfamide and paclitaxel [13, 
15], docetaxel and gemcitabine are used respectively in the first- and in the second-line 
therapy, as in our case. They often do not bring any benefit because of a high incidence of 
chemoresistance [10, 15]. 
No standard adjuvant therapy has yet been described. Palliative treatments, such as talc 
pleurodesis and pericardial drainage, can improve the quality of life but do not interfere 
with the rapid development of the disease. 
The prognosis of cardiac sarcoma is poor because not one of the treatments can be 
considered successful [9–11]. Median survival for this aggressive tumour varies between 3 
and 12 months in the majority of the literature. Surgical treatment is generally associated 
with a better prognosis and, excluding perioperative death cases, increases the survival up 
to 21 months [17]. 
In conclusion, primary heart sarcoma is a very rare and aggressive malignant tumour, 
leading to death within a few months after diagnosis. It can occur at any age and should 
be suspected in patient with sudden unspecific heart or lung symptoms, without any 
particular personal or familiar pathological history.  
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Fig. 1. CT scan during the first presentation (January 2008) revealed an abundant pericardial effusion 
with thickness of the left pericardium. 
 
 
 
Fig. 2. Two months after admission (March 2008), CT scan showed no pericardial effusion but 
bilateral lung metastasis with pleural effusion. 
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Fig. 3. Chest X-ray in May 2008 revealed bilateral pleural effusion, treated with drainage. 
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